Dublin, Ireland

Ciaran O'Reilly

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Trinity College Dublin. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ciaran O'Reilly. Retrieved from https://idiyas.com/inventor/ciaran-o-reilly

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ciaran O'Reilly: Innovator in Macrophage Migration Inhibitory Factor Research

Introduction

Ciaran O'Reilly is a notable inventor based in Dublin, Ireland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit macrophage migration inhibitory factor (MIF). His work is crucial in addressing diseases associated with MIF, showcasing his dedication to advancing medical science.

Latest Patents

Ciaran O'Reilly holds a patent for "3-phenyl-7-hydroxy-isocoumarins as macrophage migration inhibitory factor (MIF) inhibitors." This patent includes 3-phenyl-7-hydroxy-isocoumarin compounds that serve as MIF inhibitors, along with compositions comprising these inhibitors and methods for treating or preventing diseases linked to MIF. He has 1 patent to his name, reflecting his innovative approach to tackling complex health issues.

Career Highlights

O'Reilly is affiliated with the College of the Holy and Undivided Trinity of Queen Elizabeth Near Dublin, where he contributes to research and development in his field. His academic environment fosters collaboration and innovation, allowing him to explore new avenues in medicinal chemistry.

Collaborations

Throughout his career, Ciaran has worked alongside esteemed colleagues such as Seamas Donnelly and David Lloyd. These collaborations enhance the research output and contribute to the advancement of their shared goals in scientific discovery.

Conclusion

Ciaran O'Reilly's work in developing MIF inhibitors represents a significant step forward in medical research. His innovative spirit and dedication to improving health outcomes through science are commendable.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…